Clinical Trial Details
EORTC-62022
Back to Clinical Trials Database
Phase 2 study of Iressa (ZD 1839) in locally advanced and/or metastatic synovial sarcoma expressing HER1/EGFRI.
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 28-Oct-2002 Date Step1 close: 18-Oct-2005 Date Step2 close: 18-Oct-2005 |
Data management at EORTC | Yes |
Design |
Phase 2 Randomized open label |
Targeted Sample size | EORTC Groups: 44 |
Treatment | |
Study Staff | |
Type of cancer | |
Participating groups | |
Protocol summary | http://clinicaltrials.gov/study/NCT00052754 |
NCT number | NCT00052754 |